Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04301778 |
|---|---|
| Brief Title: | Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma |
| First Submitted : | March 6, 2020 |
| First Submitted that Met QC Criteria : | March 6, 2020 |
| First Posted : | March 10, 2020 |
| Results First Submitted : | March 6, 2023 |
| Results First Submitted that Met QC Criteria : | March 6, 2023 |
| Results First Posted : | March 31, 2023 |
| Last Update Submitted that Met QC Criteria : | March 6, 2023 |
| Last Update Posted : | March 31, 2023 |